TY  - GEN
AU  - Friedlander,Terence W
AU  - Weinberg,Vivian K
AU  - Small,Eric J
AU  - Sharib,Jeremy
AU  - Harzstark,Andrea L
AU  - Lin,Amy M
AU  - Fong,Lawrence
AU  - Ryan,Charles J
TI  - Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study
SN  - 1873-2496
PY  - 2012///1130
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Hormonal
KW  - adverse effects
KW  - Diarrhea
KW  - chemically induced
KW  - Drug Administration Schedule
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Fatigue
KW  - Flatulence
KW  - Humans
KW  - Insulin-Like Growth Factor Binding Protein 1
KW  - blood
KW  - Insulin-Like Growth Factor Binding Protein 3
KW  - Insulin-Like Growth Factor I
KW  - analysis
KW  - Insulin-Like Growth Factor II
KW  - Male
KW  - Middle Aged
KW  - Octreotide
KW  - Orchiectomy
KW  - Peptides
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.urolonc.2010.06.014
ER  -